Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Kegelman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Cellular Physiology|July 28, 2011
Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeuticsKeetae Kim, Seok-Geun Lee, Timothy P Kegelman, et al.
Neuro-Oncology|December 6, 2013
MDA-9/syntenin is a key regulator of glioma pathogenesisTimothy P Kegelman, Swadesh K Das, Bin Hu, et al.
Frontiers in Bioscience (Landmark Edition)|December 29, 2011
MDA-9/syntenin: a positive gatekeeper of melanoma metastasisSwadesh K Das, Sujit K Bhutia, Timothy P Kegelman, et al.
Journal of Cellular Physiology|July 7, 2011
mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancerSujit K Bhutia, Swadesh K Das, Timothy P Kegelman, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2016
Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/SynteninTimothy P Kegelman, Bainan Wu, Swadesh K Das, et al.
Cancer Research|August 20, 2011
Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicitySeok-Geun Lee, Keetae Kim, Timothy P Kegelman, et al.
Advances in Radiation Oncology|July 6, 2023
Cardiovascular Substructure Dose and Cardiac Events following Proton- and Photon-Based Chemoradiotherapy for Non-Small Cell Lung CancerJyotsna Natarajan, Nikhil Yegya-Raman, Timothy P Kegelman, et al.
Clinical and Translational Radiation Oncology|January 24, 2023
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancerNikhil Yegya-Raman, Timothy P Kegelman, Sang Ho Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2023
Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidationNikhil Yegya-Raman, Sang Ho Lee, Cole Friedes, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 31, 2012
Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesMichael Hedvat, Luni Emdad, Swadesh K Das, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Cellular Physiology|July 28, 2011
Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeuticsKeetae Kim, Seok-Geun Lee, Timothy P Kegelman, et al.
Neuro-Oncology|December 6, 2013
MDA-9/syntenin is a key regulator of glioma pathogenesisTimothy P Kegelman, Swadesh K Das, Bin Hu, et al.
Frontiers in Bioscience (Landmark Edition)|December 29, 2011
MDA-9/syntenin: a positive gatekeeper of melanoma metastasisSwadesh K Das, Sujit K Bhutia, Timothy P Kegelman, et al.
Journal of Cellular Physiology|July 7, 2011
mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancerSujit K Bhutia, Swadesh K Das, Timothy P Kegelman, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2016
Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/SynteninTimothy P Kegelman, Bainan Wu, Swadesh K Das, et al.
Cancer Research|August 20, 2011
Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicitySeok-Geun Lee, Keetae Kim, Timothy P Kegelman, et al.
Advances in Radiation Oncology|July 6, 2023
Cardiovascular Substructure Dose and Cardiac Events following Proton- and Photon-Based Chemoradiotherapy for Non-Small Cell Lung CancerJyotsna Natarajan, Nikhil Yegya-Raman, Timothy P Kegelman, et al.
Clinical and Translational Radiation Oncology|January 24, 2023
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancerNikhil Yegya-Raman, Timothy P Kegelman, Sang Ho Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2023
Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidationNikhil Yegya-Raman, Sang Ho Lee, Cole Friedes, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 31, 2012
Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesMichael Hedvat, Luni Emdad, Swadesh K Das, et al.
Pageof 2